These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 3018226)

  • 1. Short-term desensitization of muscarinic cholinergic receptors in mouse neuroblastoma cells: selective loss of agonist low-affinity and pirenzepine high-affinity binding sites.
    Cioffi CL; el-Fakahany EE
    J Pharmacol Exp Ther; 1986 Sep; 238(3):916-23. PubMed ID: 3018226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115): cyclic GMP formation is mediated by a low affinity agonist-receptor conformation and cyclic AMP reduction is mediated by a high affinity agonist-receptor conformation.
    McKinney M; Richelson E
    Mol Pharmacol; 1986 Sep; 30(3):207-11. PubMed ID: 3018477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudo-noncompetitive antagonism of muscarinic receptor-mediated cyclic GMP formation and phosphoinositide hydrolysis by pirenzepine.
    el-Fakahany EE; Surichamorn W; Amrhein CL; Stenstrom S; Cioffi CL; Richelson E; McKinney M
    J Pharmacol Exp Ther; 1988 Dec; 247(3):934-40. PubMed ID: 2849677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of muscarinic cholinergic receptor density in neuroblastoma cells by brief exposure to agonist: possible involvement in desensitization of receptor function.
    Feigenbaum P; El-Fakahany EE
    J Pharmacol Exp Ther; 1985 Apr; 233(1):134-40. PubMed ID: 3981451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
    Lee JH; el-Fakahany EE
    J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    Fisher SK
    Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
    Gillard M; Waelbroeck M; Christophe J
    Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
    Lazareno S; Buckley NJ; Roberts FF
    Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-term regulation of muscarinic acetylcholine receptor binding in cultured nerve cells.
    Feigenbaum P; El-Fakahany EE
    Res Commun Chem Pathol Pharmacol; 1984 Mar; 43(3):519-22. PubMed ID: 6718813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of agonist efficacy on desensitization of phosphoinositide hydrolysis mediated by m1 and m3 muscarinic receptors expressed in Chinese hamster ovary cells.
    Hu J; Wang SZ; el-Fakahany EE
    J Pharmacol Exp Ther; 1991 Jun; 257(3):938-45. PubMed ID: 1710663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
    Ehlert FJ; Jenden DJ
    Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic receptors in the stomach.
    Hammer R
    Scand J Gastroenterol Suppl; 1980; 66():5-11. PubMed ID: 6941378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The putative M1 muscarinic receptor does not regulate phosphoinositide hydrolysis. Studies with pirenzepine and McN-A343 in chick heart and astrocytoma cells.
    Brown JH; Goldstein D; Masters SB
    Mol Pharmacol; 1985 May; 27(5):525-31. PubMed ID: 2581122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain.
    Perry EK; Smith CJ; Perry RH; Whitford C; Johnson M; Birdsall NJ
    J Chem Neuroanat; 1989; 2(4):189-99. PubMed ID: 2597358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple binding affinities of N-methylscopolamine to brain muscarinic acetylcholine receptors: differentiation from M1 and M2 receptor subtypes.
    el-Fakahany EE; Ramkumar V; Lai WS
    J Pharmacol Exp Ther; 1986 Aug; 238(2):554-63. PubMed ID: 3755473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.